September 5, 2025Open Access

Ovarian Cancer Therapy in Transition, Innovation, Update, and Challenges: A Review Article

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Review article highlights therapeutic strategies and patient demographics in ovarian cancer, indicating ongoing challenges.

Recent advancements in ovarian cancer therapies have improved survival odds for some patients, and further investigation into treatment strategies is needed.
Analysis of six key therapeutic strategies—ICIs, PARP inhibitors, ADCs—provides insights into efficacy and patient demographics while addressing current gaps.
Innovative approaches highlight the importance of biomarker development to improve combination therapies and reduce resistance to treatment.
Research emphasizes that high-risk patients require further studies to validate findings and ultimately lower the ovarian cancer burden.

Wassan Nori (2025) studied this question.

View Full Paper

Ask AI

Bookmark